Menu

Snake Venoms Cause and Block Pain

Painful snake bites may hold clues to developing analgesic drugs.

Jan 1, 2018
Kerry Grens

© Matthijs Kuijpers/ALAMY STOCK PHOTO Snakes represent some of the deadliest venomous animals in the world, killing between 81,000 and 138,000 people each year, according to the World Health Organization. But in low doses, some of their toxins can produce analgesia.

For instance, a toxin from the black mamba (Dendroaspis polylepis) inhibits pain by blocking acid-sensing ion channels on the surface of pain-transmitting neurons in mice (Nature, 490:552-55, 2012). Another compound, taken from the venom of the king cobra (Ophiophagus hannah), likewise diminishes pain but acts in an unusual way. R. Manjunatha Kini of the National University of Singapore has found that so-called hannalgesin likely disrupts nitric oxide synthase in neurons, thereby reducing nitric oxide production, which is involved in pain. “There are many ways of skinning a cat, and there could be many ways to block pain,” says Kini.

Although both toxins helped launch companies looking to develop analgesics in recent years, neither progressed, principally because of economic and other circumstances beyond the science, Kini says.

Toxins that cause pain can be just as useful as those which block pain because they can teach us more about how pain works.—Bryan Fry, University of Queensland

The University of Queensland’s Bryan Fry says snake venoms could contribute to pain therapeutics in ways other than by tapping into their analgesic components: by zeroing in on venom compounds that cause pain. In 2016, Fry’s group described the mechanism by which the toxin of the long-glanded blue coral snake (Calliophis bivirgatus) acts upon the NaV1.4 voltage-gated sodium channel (Toxins, 8:303, 2017), “therefore revealing a new target for drug design,” he says in an email to The Scientist. “Toxins that cause pain can be just as useful as those which block pain, because they can teach us more about how pain works.”

Read about other animal groups researchers are exploring for pain-killing leads in the full feature story, “Animal Analgesics.”

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.